Oura unveils new hormonal health features that include tracking for birth control and menopause.

Oura unveils new hormonal health features that include tracking for birth control and menopause.

      Oura introduces new hormonal health features for women worldwide

      ŌURA has unveiled a significant update to its smart ring platform, launching new features centered on hormonal health. Beginning May 6, the company will introduce Hormonal Birth Control support and Menopause Insights globally, marking an important enhancement to its women's health offerings.

      A Move Towards More Personalized Health Tracking

      This update includes two main components. First, Hormonal Birth Control support expands upon Oura’s existing Cycle Insights feature. It enables users to log various forms of contraception, including pills, patches, IUDs, and implants, while monitoring how these methods influence metrics such as body temperature, sleep, and recovery. The aim is to clarify the relationship between hormonal fluctuations and daily physiological data, an aspect that has often lacked comprehensive tracking tools.

      The second component, Menopause Insights, addresses perimenopause and menopause—stages that are frequently underrepresented in digital health applications. Central to this feature is a unique Menopause Impact Scale that evaluates how symptoms impact day-to-day life. Users will receive a personalized dashboard that tracks patterns over time and correlates symptoms with biometric data gathered from the Oura Ring.

      The Timeliness of This Update

      This update signifies a larger trend in the health tech industry towards more individualized and data-driven insights. Hormonal health has historically been considered a secondary concern in both medicine and technology, despite its widespread impact on the global population.

      By merging hormonal context with ongoing biometric tracking, Oura seeks to fill this gap. The company emphasizes that these features go beyond generic symptom tracking, providing more organized and personalized insights. This approach may enhance users' understanding of long-term bodily changes, particularly during complex life stages like menopause.

      Implications for Users

      For users, these new features offer a more comprehensive understanding of how hormonal changes affect their everyday health metrics. Rather than relying on disconnected data points or general guidance, users can observe patterns over time and relate them to their own experiences.

      The platform also allows users to share this information with healthcare professionals, potentially improving consultations and treatment decisions. In the U.S., Oura is collaborating with healthcare provider Twentyeight Health to facilitate integrated access to contraception services, including virtual consultations and prescriptions.

      Future Developments

      These additions form part of Oura’s broader vision to create a thorough ecosystem for women's health. The company has already rolled out features such as Cycle Insights, Fertile Window tracking, and Pregnancy Insights, as well as an AI model designed to analyze women’s health data.

      Oura is also collaborating with clinical partners and research organizations to broaden the application of its biometric data in real-world healthcare scenarios. As these initiatives progress, the company aims to position its platform as a long-term health companion that evolves through different life stages, from early cycles to menopause and beyond.

Oura unveils new hormonal health features that include tracking for birth control and menopause. Oura unveils new hormonal health features that include tracking for birth control and menopause. Oura unveils new hormonal health features that include tracking for birth control and menopause. Oura unveils new hormonal health features that include tracking for birth control and menopause. Oura unveils new hormonal health features that include tracking for birth control and menopause. Oura unveils new hormonal health features that include tracking for birth control and menopause. Oura unveils new hormonal health features that include tracking for birth control and menopause.

Other articles

Similar to the MacBook Neo, Apple may deliver another pricing shock with the iPhone 18 Pro. Similar to the MacBook Neo, Apple may deliver another pricing shock with the iPhone 18 Pro. A leak regarding the pricing of the iPhone 18 Pro indicates that Apple might expand the distinction between the Pro and standard models, adopting a strategy akin to its MacBook Neo method. Twelve electric vehicle models have been phased out in the US due to tariffs, the loss of tax credits, and increased import costs altering the market. Twelve electric vehicle models have been phased out in the US due to tariffs, the loss of tax credits, and increased import costs altering the market. Tesla, Honda, BMW, Volvo, Hyundai, and Kia have withdrawn their electric vehicles from the US market in 2026. The issue is not related to the technology; rather, it is the trade policy. Alphabet approaches Nvidia in the race to become the world's most valuable company following strong Q1 earnings in cloud services, search, and AI. Alphabet approaches Nvidia in the race to become the world's most valuable company following strong Q1 earnings in cloud services, search, and AI. Alphabet's market capitalization reached $4.6 trillion following a 22% increase in Q1 earnings. Google Cloud experienced a growth of 63%. Nvidia saw a decline of 6%. The gap has narrowed to $200 billion. Oura launches features for hormonal health, including tracking for birth control and menopause. Oura launches features for hormonal health, including tracking for birth control and menopause. Oura unveils new features for hormonal health, which include tracking birth control and providing insights on menopause, with the goal of linking biometric information to actual physiological changes. VW, Toyota, and Hyundai are relying on Chinese tech partners as local brands dominate 70% of the market. VW, Toyota, and Hyundai are relying on Chinese tech partners as local brands dominate 70% of the market. The early 2026 market share increases for foreign automakers in China indicate a lingering effect of subsidies rather than a resurgence. The technology disparity has shifted. Twelve electric vehicle models have been discontinued in the US as tariffs, the loss of tax credits, and rising import costs alter the market landscape. Twelve electric vehicle models have been discontinued in the US as tariffs, the loss of tax credits, and rising import costs alter the market landscape. In 2026, Tesla, Honda, BMW, Volvo, Hyundai, and Kia have all withdrawn their electric vehicles from the US market. The reason behind this is not the technology but rather the trade policy.

Oura unveils new hormonal health features that include tracking for birth control and menopause.

Oura unveils new features for hormonal health, which encompass tracking birth control and providing insights on menopause, with the goal of linking biometric data to real-life physiological changes.